Health ProductsType I recall

Inderal-LA: Nitrosamine Impurity

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Issue: Health products - Contamination
What to do: Contact your health care provider to discuss other treatment options. While there are no other companies marketing extended release propranolol in Canada, immediate release propranolol products continue to be available, along with other treatment options. Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Product NameDosage FormBrandLotMarket AuthorizationStrength
Inderal-LA 120mgCapsule (Extended Release)Pfizer Inderal-LAFE0541, EH5908, DX6159, DJ6820DIN 02042266Propanolol Hydrochloride 120mg
Inderal-LA 160mgCapsule (Extended Release)Pfizer Inderal-LAFE6304, EH5906, DW8241DIN 02042274Propanolol Hydrochloride 160mg
Inderal-LA 60mgCapsule (Extended Release)Pfizer Inderal-LAEX7461, EH5907, DX6150DIN 02042231Propanolol Hydrochloride 60mg
Inderal-LA 80mgCapsule (Extended Release)Pfizer Inderal-LAEX7462, EL1695, EE7221, DW8242DIN 02042258Propanolol Hydrochloride 80mg

Issue

Presence of impurity N-Nitroso-propanolol above the acceptable concentration limit in affected lots.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime